Parvovirus infection in adults: a series of case reports in post-pandemic period
PDF (Українська)

Keywords

parvovirus B19
anemia
thrombocytopenia
leukopenia
hepatitis
pericarditis

How to Cite

Kondratiuk, L., & Bezrodna, O. (2024). Parvovirus infection in adults: a series of case reports in post-pandemic period. Medicine Today and Tomorrow, 93(3). https://doi.org/10.35339/msz.2024.93.3.kob

Abstract

In press

Parvovirus infection in immunocompetent patients usually has a mild or asymptomatic course, but some cases may be characterized by a complicated course that requires hospitalization. The aim of our work was the characterization of clinical course of parvovirus infection in immunocompetent patients who required hospitalization. The article discussed three clinical cases of infection caused by human parvovirus B19. Our patients had a pronounced general intoxication syndrome with fever, severe anemia, hepatitis with moderate biochemical activity, and splenomegaly in the first clinical case; erythema multiforme, severe thrombocytopenia and leukopenia in the second clinical case; pericarditis with purple rash in the third clinical case. Patients with immunosuppression could have chronic anemia, pancytopenia, myocarditis, pneumonitis, hepatitis, meningitis, and encephalitis in a course of parvovirus infection. HIV infection was ruled out for all our patients; however, these patients were routinely recommended to undergo additional examinations in order to rule out other possible causes of immunosuppression. Clinical vigilance regarding parvovirus infection is currently relevant, and complex specific diagnostics (serological, immunoblotting and Polymerase Chain Reaction assays) are available and cоuld be used in diagnostic cases to determine the tactics of further examination and treatment.

Keywords: parvovirus B19, anemia, thrombocytopenia, leukopenia, hepatitis, pericarditis.

https://doi.org/10.35339/msz.2024.93.3.kob
PDF (Українська)

References

Kerr JR, Bracewell J, Laing I, Mattey DL, Bernstein RM, Bruce IN, Tyrrell DA. Chronic fatigue syndrome and arthralgia following parvovirus B19 infection. J Rheumatol. 2002;29(3):595-602. PMID: 11911112.

Mage V, Lipsker D, Barbarot S, Bessis D, Chosidow O, Del Giudice P, et al. Different patterns of skin manifestations associated with parvovirus B19 primary infection in adults. J Am Acad Dermatol. 2014;71(1):62-9. DOI: 10.1016/j.jaad.2014.02.044. PMID: 24726401.

Landry ML. Parvovirus B19. Microbiol Spectr. 2016;4(3). DOI: 10.1128/microbiolspec.DMIH2-0008-2015. PMID: 27337440.

El-Mahallawy HA, Mansour T, El-Din SE, Hafez M, Abd-el-Latif S. Parvovirus B19 infection as a cause of anemia in pediatric acute lymphoblastic leukemia patients during maintenance chemotherapy. J Pediatr Hematol Oncol. 2004;26(7):403-6. DOI: 10.1097/00043426-200407000-00001. PMID: 15218412.

Graeve JL, de Alarcon PA, Naides SJ. Parvovirus B19 infection in patients receiving cancer chemotherapy: the expanding spectrum of disease. Am J Pediatr Hematol Oncol. 1989;11(4):441-4. PMID: 2559623.

Eid AJ, Brown RA, Patel R, Razonable RR. Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis. 2006;43(1):40-8. DOI: 10.1086/504812. PMID: 16758416.

Young NS, Brown KE. Parvovirus B19. N Engl J Med. 2004;350(6):586-97. DOI: 10.1056/NEJMra030840. PMID: 14762186.

Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med. 1998;338(24):1741-51. DOI: 10.1056/NEJM199806113382407. PMID: 9624195.

Crane J, Mundle W, Boucoiran I; Maternal Fetal Medicine Committee. Parvovirus B19 infection in pregnancy. J Obstet Gynaecol Can. 2014;36(12):1107-16. DOI: 10.1016/S1701-2163(15)30390-X. PMID: 25668048.

Mustafa MM, McClain KL. Diverse hematologic effects of parvovirus B19 infection. Pediatr Clin North Am. 1996;43(3):809-21. DOI: 10.1016/s0031-3955(05)70434-x. PMID: 8649911.

Brown KE, Bennet JE, Dolin R, Blaser M. Mandell, Douglas and Bennett's Principals and Practice of Infectious Diseases. 8th ed. Philadelphia, PA: Churchill Livingstone Elsevier; 2015. Vol. 2. P. 1840-7.

Yoto Y, Kudoh T, Haseyama K, Suzuki N, Chiba S. Human parvovirus B19 infection associated with acute hepatitis. Lancet. 1996;347(9005):868-9. DOI: 10.1016/s0140-6736(96)91348-3. PMID: 8622394.

Seishima M, Shibuya Y, Watanabe K, Kato G. Pericarditis and pleuritis associated with human parvovirus B19 infection in a systemic lupus erythematosus patient. Mod Rheumatol. 2010;20(6):617-20. DOI: 10.1007/s10165-010-0330-6. PMID: 20607339.

Anderson MJ, Higgins PG, Davis LR, Willman JS, Jones SE, Kidd IM, et al. Experimental parvoviral infection in humans. J Infect Dis. 1985;152(2):257-65. DOI: 10.1093/infdis/152.2.257. PMID: 2993431.

American Academy of Pediatrics Committee on Infectious Diseases. Parvovirus B19. Kimberlin DW, Brady M, Jackson SA, Long SS, eds. 2015 Red Book: Report of the Committee on Infectious Diseases. 30th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2015. P. 593-6.

Soderlund-Venermo M, Hokynar K, Nieminen J, Rautakorpi H, Hedman K. Persistence of human parvovirus B19 in human tissues. Pathol Biol (Paris). 2002;50(5):307-16. DOI: 10.1016/s0369-8114(02)00307-3. PMID: 12116849.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.